APT Medical Inc. (688617.SS) — Stock Score Summary

APT Medical Inc. (688617.SS) has a MoatMap StockRank of 66/100 based on Quality (90/100), Value (19/100), and Momentum (41/100) factor scores. The current signal is BUY. APT Medical is a premier Chinese medical device company with exceptional quality metrics (Q: 90). It is a prime beneficiary of China's domestic substitution policy in high-end medical consumables (electrophysiology). However, geopolitical risks and high domestic valuation prevent a high-conviction buy at this stage.

APT Medical Inc. is a leading developer and manufacturer of minimally invasive interventional medical devices, specializing in electrophysiology (EP) and vascular access. The company is a domestic pioneer in China's EP market, offering a comprehensive portfolio of diagnostic and ablation catheters that compete with multinational giants. Its competitive moat is sustained by proprietary manufacturing processes for micro-catheters and a strong clinical training network for cardiologists.

Key Financial Metrics

Price$29.41
Market Cap$4.3B
P/E (TTM)32.80
P/E (Forward)22.27
Price/Book9.47
Return on Equity29.7%
Return on Invested Capital29.4%
Debt/Equity0.48
Gross Margin72.5%
Operating Margin37.5%
Revenue Growth24.8%
Dividend Yield0.5%
Free Cash Flow$8M

APT Medical Inc. operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is APT Medical Inc.’s (688617.SS) StockRank?
MoatMap’s StockRank for APT Medical Inc. (688617.SS) is 66/100, with a Buy signal. It is a composite of Quality (90), Value (19), and Momentum (41) factor ranks across MoatMap’s 19,000+ stock universe.
Does APT Medical Inc. have an economic moat?
APT Medical Inc. (688617.SS) has a Quality factor score of 90/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is APT Medical Inc. a buy, hold, or sell?
MoatMap’s current signal for APT Medical Inc. (688617.SS) is Buy, based on a StockRank of 66/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is APT Medical Inc. in?
APT Medical Inc. (688617.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).